🇺🇸 FDA
Patent

US 10640501

Methods of preparing inhibitors of influenza viruses replication

granted A61KA61K31/506A61P

Quick answer

US patent 10640501 (Methods of preparing inhibitors of influenza viruses replication) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/506, A61P, A61P31/16